What is Ganoderma lucidum in the molecular era?

Viktor Papp, Bálint Dima, Solomon P. Wasser

Research output: Contribution to journalArticlepeer-review


The scientific name Ganoderma lucidum has long been used in the global medicinal mushroom market, and many publications have proven its pharmacological properties and chemical components. Although several Ganoderma species have been described worldwide as having morphology considerably similar to that of G. lucidum s. str., this binomial is still the most frequently used in pharmacological studies. However, the use of particularly divergent nomenclature has caused major difficulties in the evaluation of the results of pharmacological studies. This article is intended to provide a nomenclatural and taxonomic overview of the medically important G. lucidum group, that is, G. lucidum aggregate and G. lingzhi. Moreover, we evaluate the possibilities of how nomenclatural changes can help to avoid misunderstandings in thousands of publications and highlight scientifically correct interpretations for future studies.

Original languageEnglish
Pages (from-to)575-593
Number of pages19
JournalInternational Journal of Medicinal Mushrooms
Issue number7
StatePublished - 2017

Bibliographical note

Publisher Copyright:
© 2017 Begell House, Inc.


  • Barcode
  • Ganoderma lingzhi
  • Ganoderma lucidum
  • Lingzhi
  • Medicinal mushrooms
  • Nomenclature
  • Phylogeny
  • Reishi

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Drug Discovery
  • Pharmacology


Dive into the research topics of 'What is Ganoderma lucidum in the molecular era?'. Together they form a unique fingerprint.

Cite this